BAXTER INTERNATIONAL INC acquired Baxa Corporation for $380M, a transaction completed in November 2011, structured as All-cash acquisition of a privately held company.
Baxa Corporation operates in Medical Products, is based in Englewood, Colorado, United States. Baxter completed its acquisition of Baxa Corporation, a privately held global company based in Englewood, Colorado that develops pharmacy technology for the safe and efficient preparation and delivery of oral and IV doses. The acquired portfolio included the ExactaMix compounders, ExactaMed oral syringes, the NeoThrive enteral feeding system, and the DoseEdge pharmacy workflow manager. Baxa's annual sales were $157 million in 2010, and Baxter expected the business to be accretive to future sales growth.
Deepened Baxter's commitment to nutrition and patient safety by broadening its range of solutions for the safe preparation and delivery of IV and oral liquid medications, complementing its fluid- and drug-delivery portfolio.
Advisory firms were not disclosed for this transaction.